Journal of Southern Medical University ›› 2024, Vol. 44 ›› Issue (11): 2121-2130.doi: 10.12122/j.issn.1673-4254.2024.11.08
Hong YAO1,2(), Kedi LIU2(
), Chengzhao LIU2, Weihong LI2,3, Qi DAI2, Shi ZHAO2, Ziheng DING1,2, Hefei WANG1,2, Xiaojing GE4, Peifeng WEI1,5, Jialin DUAN6(
), Miaomiao XI2,5(
)
Received:
2024-06-14
Online:
2024-11-20
Published:
2024-11-29
Contact:
Jialin DUAN, Miaomiao XI
E-mail:yao520hong1314@163.com;pepperyfat@163.com;dogson1989@163.com;miaomiaoxi2014@163.com
Hong YAO, Kedi LIU, Chengzhao LIU, Weihong LI, Qi DAI, Shi ZHAO, Ziheng DING, Hefei WANG, Xiaojing GE, Peifeng WEI, Jialin DUAN, Miaomiao XI. Maggot alleviates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting immune stress and complement activation[J]. Journal of Southern Medical University, 2024, 44(11): 2121-2130.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.j-smu.com/EN/10.12122/j.issn.1673-4254.2024.11.08
Score | Severity | Erythema (E) | Infitration (I) | Desquamation (D) | Area of psoriatic involvement (%) |
---|---|---|---|---|---|
0 | None | No erythema | No infitration | No scales | 0 |
1 | Slight | Slight erythema | The injured skin is slightly raised. | Some of the injured skin is covered with fine scales. | <10 |
2 | Moderate | Moderate erythema | The injured skin is moderately raised, and the edge of the plaque is round or sloping. | Most of the injured skin is completely or incompletely covered with flaky scales. | 10-29 |
3 | Marked | Striking erythema | The injured skin is markedly raised and thickened. | Almost all of the injured skin is covered with thick and layered scales. | 30-49 |
4 | Very marked | Exceptionally striking erythema | The injured skin is very markedly raised and thickened. | All of the injured skin is covered with very thick and layered scales. | 50-69 |
5 | - | - | - | - | 70-89 |
6 | - | - | - | - | 90-100 |
Tab.1 Psoriasis area and severity index in mice (MPASI)
Score | Severity | Erythema (E) | Infitration (I) | Desquamation (D) | Area of psoriatic involvement (%) |
---|---|---|---|---|---|
0 | None | No erythema | No infitration | No scales | 0 |
1 | Slight | Slight erythema | The injured skin is slightly raised. | Some of the injured skin is covered with fine scales. | <10 |
2 | Moderate | Moderate erythema | The injured skin is moderately raised, and the edge of the plaque is round or sloping. | Most of the injured skin is completely or incompletely covered with flaky scales. | 10-29 |
3 | Marked | Striking erythema | The injured skin is markedly raised and thickened. | Almost all of the injured skin is covered with thick and layered scales. | 30-49 |
4 | Very marked | Exceptionally striking erythema | The injured skin is very markedly raised and thickened. | All of the injured skin is covered with very thick and layered scales. | 50-69 |
5 | - | - | - | - | 70-89 |
6 | - | - | - | - | 90-100 |
Fig.1 Effect of maggot MPASI score in psoriasis (PSO) mice. A: Skin lesions on day 1 and day 9 in the groups. B: Maggot significantly decreased MPASI score in PSO mice (Mean±SD, n=6). ***P<0.001 vs Control group; ###P<0.001 vs Model group.
Fig.2 Effect of maggot on thickness of swelling auricle in PSO mice. A: Skin lesions in the right (shown on the left) and left ear (on the right) in mice. B: Maggot significantly decreased the auricle swelling thickness in PSO mice (Mean±SD, n=6). ***P<0.001 vs Control group; #P<0.05, ###P<0.001 vs Model group.
Fig.3 Effect of maggot on histopathological changes in PSO mice. A: Maggot significantly improved pathological changes of back skin lesions in PSO mice (Scale bar=50 μm). B: Maggot significantly improved pathological changes in right ear lesions in PSO mice (Scale bar=100 μm).
Fig.4 Maggot significantly decreased the number of scratching of PSO mice (Mean±SD, n=6). ***P<0.001 vs Control group; ##P<0.01, ###P<0.001 vs Model group.
Fig.5 Effect of maggot on spleen index in PSO mice. A: Comparison of mice spleen. B: Maggot significantly decreased the spleen index in PSO mice (Mean±SD, n=6). ***P<0.001 vs Control group; ###P<0.001 vs Model group.
Fig.6 Effect of maggot on the number of mast cells in PSO mice. A: Toluidine blue staining of dorsal skin lesions in mice (Scale bar=50 μm). B: Maggot significantly decreased the number of mast cells in PSO mice (Mean±SD, n=6). ***P<0.001 vs Control group; ##P<0.01, ###P<0.001 vs Model group.
Fig.8 Effect of maggot on levels of complements in PSO mice (Mean±SD, n=6). A-F: Serum levels of CH50, C3, C5, C1s, C3a and C5a. G-K: C1s, C3, C3a, C5 and C5a contents in the skin tissue. *P<0.05, ***P<0.001vs Control group; #P<0.05, ##P<0.01, ###P<0.001 vs Model group.
Fig.9 Effect of maggot on serum levels IL-23 (A), IL-17A (B) and TNF-α (C) in PSO mice (Mean±SD, n=6). **P<0.01, ***P<0.001 vs Control group; #P<0.05, ###P<0.001 vs Model group.
1 | 中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南(2023版)[J]. 中华皮肤科杂志, 2023, 56(7): 573-625. |
2 | Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. Psoriasis[J]. Lancet, 2021, 397(10281): 1301-15. |
3 | Schett G, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs[J]. N Engl J Med, 2021, 385(7): 628-39. |
4 | Hirobe S, Yamasaki T, Ito S, et al. Transcutaneous administration of imiquimod promotes T and B cell differentiation into effector cells or plasma cells[J]. Pharmaceutics, 2022, 14(2): 385. |
5 | Cyster JG, Allen CDC. B cell responses: cell interaction dynamics and decisions[J]. Cell, 2019, 177(3): 524-40. |
6 | Mastellos DC, Hajishengallis G, Lambris JD. A guide to complement biology, pathology and therapeutic opportunity[J]. Nat Rev Immunol, 2024, 24(2): 118-41. |
7 | Qiao P, Zhi DL, Yu C, et al. Activation of the C3a anaphylatoxin receptor inhibits keratinocyte proliferation by regulating keratin 6, keratin 16, and keratin 17 in psoriasis[J]. FASEB J, 2022, 36(5): e22322. |
8 | Zheng QY, Liang SJ, Xu F, et al. C5a/C5aR1 pathway is critical for the pathogenesis of psoriasis[J]. Front Immunol, 2019, 10: 1866. |
9 | 蔺 瑞, 边海旭, 郭 超, 等. 五谷虫的药理作用研究进展[J]. 中国药房, 2017, 289(4): 558-61. DOI: 10.6039/j.issn.1001-0408.2017.04.35 |
10 | 张 玮, 石晓丽, 刘一凡, 等. 中药五谷虫活性肽-酶类化学成分研究进展[J]. 时珍国医国药, 2022, 33(8): 1978-82. |
11 | Shamloul G, Khachemoune A. Reappraisal and updated review of maggot debridement therapy in chronic lower extremity ulcers[J]. Int J Dermatol, 2023, 62(7): 962-8. |
12 | 杭小涵, 李 雪, 李 楠, 等. 基于p38MAPK/NF-κB信号通路探讨外用应急软膏治疗银屑病的机制研究[J]. 世界临床药物, 2023, 44(3): 215-9, 251. DOI: 10.13683/j.wph.2023.03.004 |
13 | Peng F, Zong J, Zhao T, et al. Anti-inflammatory and immunomodulatory effects of polysaccharide extracted from Wuguchong (maggot) on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice[J]. Front Pharmacol, 2023, 14: 1119103. |
14 | van der Plas MJ, van der Does AM, Baldry M, et al. Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses[J]. Microbes Infect, 2007, 9(4): 507-14. |
15 | Cazander G, Schreurs MW, Renwarin L, et al. Maggot excretions affect the human complement system[J]. and, 2012, 20(6): 879-86. |
16 | 张海龙, 安月鹏, 崔晓倩, 等. 通过调控滤泡性辅助性T细胞亚群研究蜈蚣败毒饮治疗银屑病模型鼠的机制[J]. 中国皮肤性病学杂志, 2022, 36(8): 890-7. DOI: 10.13735/j.cjdv.1001-7089.202111204 |
17 | Zhao F, Wang YJ, Zuo HJ, et al. Cyclin-Dependent kinase 9 (CDK9) inhibitor Atuveciclib ameliorates Imiquimod-Induced Psoriasis-Like dermatitis in mice by inhibiting various inflammation factors via STAT3 signaling pathway[J]. Int Immunopharmacol, 2024, 129: 111652. |
18 | 郭智玮, 晋红中. 银屑病伴瘙痒的临床特点、发病机制及治疗研究进展[J]. 中华皮肤科杂志, 2020, 53(12): 1029-32. DOI: 10.35541/cjd.20190683 |
19 | 何亚男, 蔡 翔, 邱百怡, 等. 穿心莲内酯调节cGAS-STING信号通路对银屑病小鼠的治疗作用[J]. 天津医药, 2024, 52(4): 379-86. |
20 | Sulthana S, Chary PS, Bhavana V, et al. Development and evaluation emulgel for effective management of the imiquimod-induced psoriasis[J]. Inflammopharmacology, 2023, 31(1): 301-20. |
21 | Zhang S, Zhang J, Yu JJ, et al. Hyperforin ameliorates imiquimod-induced psoriasis-like murine skin inflammation by modulating IL-17A-producing γδ T cells[J]. Front Immunol, 2021, 12: 635076. |
22 | Zhang YJ, Shi YQ, Lin JX, et al. Immune cell infiltration analysis demonstrates excessive mast cell activation in psoriasis[J]. Front Immunol, 2021, 12: 773280. |
23 | 张 喻, 向雪川, 周正繁, 等. 龙珠软膏对银屑病模型小鼠治疗作用的研究[J]. 中国医院药学杂志, 2023, 43(8): 897-902, 909. DOI: 10.13286/j.1001-5213.2023.08.12 |
24 | Syzon OO, Dashko MO, Fedorova UV. Modern specific features and therapy of psoriasis and arthropathic psoriasis courses[J]. Wiad Lek, 2018, 71(2 pt 1): 322-5. |
25 | Giang J, Seelen MAJ, van Doorn MBA, et al. Complement activation in inflammatory skin diseases[J]. Front Immunol, 2018, 9: 639. |
26 | Costabile M. Measuring the 50% haemolytic complement (CH50) activity of serum[J]. J Vis Exp, 2010(37): 1923. |
27 | Laumonnier Y, Karsten CM, Köhl G, et al. Characterization of anaphylatoxin receptor expression and C3a/C5a functions in anaphylatoxin receptor reporter mice[J]. Curr Protoc Immunol, 2020, 130(1): e100. |
28 | Ling M, Murali M. Analysis of the complement system in the clinical immunology laboratory[J]. Clin Lab Med, 2019, 39(4): 579-90. |
29 | Hashimoto T, Tsuruta D, Yasukochi A, et al. Granular C3 dermatosis[J]. Acta Derm Venereol, 2016, 96(6): 748-53. |
30 | Ring J, Senter T, Cornell RC, et al. Complement and immunoglobulin deposits in the skin of patients with atopic dermatitis[J]. Br J Dermatol, 1978, 99(5): 495-501. |
31 | Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review[J]. JAMA, 2020, 323(19): 1945-60. |
32 | Liu LJ, Zhang HL, Tang XR, et al. Geniposide ameliorates psoriatic skin inflammation by inhibiting the TLR4/MyD88/NF‑κB p65 signaling pathway and MMP9[J]. Int Immunopharmacol, 2024, 133: 112082. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||